Starpharma receives $7.1M R&D tax incentive refund (ASX announcement)

Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY) today announces it has received a $7.1M research and development (R&D) tax incentive refund under the Australian Federal Government’s R&D Tax Incentive scheme.

Related Keywords

Australia ,Australian ,Jackie Fairley ,Starpharma Holdings Limited ,Holdings Limited ,Australian Federal Government ,Australian Government ,Ceo ,Pharmaceuticals ,Tax ,Tax Incentive ,